This HTML5 document contains 103 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
wdt	http://www.wikidata.org/prop/direct/
wdtn	http://www.wikidata.org/prop/direct-normalized/
n12	http://dx.doi.org/10.1016/
schema	http://schema.org/
rdfs	http://www.w3.org/2000/01/rdf-schema#
skos	http://www.w3.org/2004/02/skos/core#
wikibase	http://wikiba.se/ontology#
p	http://www.wikidata.org/prop/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n5	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdh	http://www.w3.org/2001/XMLSchema#
wds	http://www.wikidata.org/entity/statement/
wd	http://www.wikidata.org/entity/

Statements

Subject Item

wd:Q46883619

rdf:type

wikibase:Item

schema:description

مقالة علمية نشرت في 26 نوفمبر 2007 tudományos cikk 2007年の論文 bilimsel makale artigo científico επιστημονικό άρθρο scientific article published on 26 November 2007 2007年学术文章 bài báo khoa học บทความทางวิทยาศาสตร์ научни чланак artículo científico publicado en 2007 videnskabelig artikel 2007年学术文章 научни чланак article scientifique 2007年学术文章 2007年學術文章 מאמר מדעי artikulong pang-agham articol științific vetenskaplig artikel 2007年学术文章 vitenskapelig artikkel 2007年學術文章 teaduslik artikkel vědecký článek tieteellinen artikkeli научна статия scienca artikolo article científic article scientific 2007年學術文章 naučni članak 2007年学术文章 vitskapeleg artikkel 2007年學術文章 artigo científico scientific article published on 26 November 2007 wetenschappelijk artikel 2007年学术文章 наукова стаття, опублікована в листопаді 2007 2007년 논문 articolo scientifico 2007 nî lūn-bûn artículu científicu artigo científico სამეცნიერო სტატია ২৬ নভেম্বর ২০০৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ мақолаи илмӣ научная статья wissenschaftlicher Artikel vedecký článok artykuł naukowy 2007年學術文章 artikull shkencor artikel ilmiah scientific article published on 26 November 2007

p:P577

wds:Q46883619-E4D1E532-CA38-4332-8033-CC133F29ABCF

wdt:P577

2007-11-26T00:00:00Z

p:P2093

wds:Q46883619-F8F70E50-58ED-4568-A944-8E62F806973E wds:Q46883619-964430DC-1B8C-4DEA-840A-98DBA405D64E wds:Q46883619-E14303C5-85C9-4BF6-BD20-6490464394C6 wds:Q46883619-0957C573-A47C-41C7-B939-E482FAC33956 wds:Q46883619-6A4F0F2B-66BB-41EC-8521-90BCA1EEEEFB wds:Q46883619-166C6E48-C9DA-4327-810C-DB92E7B3E1D5 wds:Q46883619-225709A6-19FC-489B-8B42-46AF69AA9286

wdt:P2093

Gunther Klautke Sabine Semrau Kaja Ludwig Ernst Klar Thomas Foitzik Ute Küchenmeister Friedrich Prall

rdfs:label

Intensified irinotecan-based neoadjuvant chemoradiotherapy in rectal cancer: four consecutive designed studies to minimize acute toxicity and to optimize efficacy measured by pathologic complete response. Intensified irinotecan-based neoadjuvant chemoradiotherapy in rectal cancer: four consecutive designed studies to minimize acute toxicity and to optimize efficacy measured by pathologic complete response.

skos:prefLabel

Intensified irinotecan-based neoadjuvant chemoradiotherapy in rectal cancer: four consecutive designed studies to minimize acute toxicity and to optimize efficacy measured by pathologic complete response. Intensified irinotecan-based neoadjuvant chemoradiotherapy in rectal cancer: four consecutive designed studies to minimize acute toxicity and to optimize efficacy measured by pathologic complete response.

schema:name

Intensified irinotecan-based neoadjuvant chemoradiotherapy in rectal cancer: four consecutive designed studies to minimize acute toxicity and to optimize efficacy measured by pathologic complete response. Intensified irinotecan-based neoadjuvant chemoradiotherapy in rectal cancer: four consecutive designed studies to minimize acute toxicity and to optimize efficacy measured by pathologic complete response.

p:P50

wds:Q46883619-79030C99-5F01-4C91-8D36-9058253BC206

wdt:P50

wd:Q64584867

p:P1476

wds:Q46883619-FA2452B5-729A-4F85-833C-5CC51276588D

wdt:P1476

Intensified irinotecan-based neoadjuvant chemoradiotherapy in rectal cancer: four consecutive designed studies to minimize acute toxicity and to optimize efficacy measured by pathologic complete response.

p:P304

wds:Q46883619-05331B7A-87FF-4F54-8488-996173205938

wdt:P304

379-384

p:P31

wds:Q46883619-45A83D60-05D3-4460-835A-05D630EF5EA0

wdt:P31

wd:Q13442814

p:P921

wds:Q46883619-8887BE63-C203-4DEF-AA9A-228B729732E9

wdt:P921

wd:Q5090613

p:P698

wds:Q46883619-BBFC5935-91D4-47C3-B6F3-884E7D80929E

wdtn:P698

n5:18036687

wdt:P698

18036687

p:P1433

wds:Q46883619-D29C084B-ED2D-4A11-A28B-84D78D674AFE

wdt:P1433

wd:Q14251029

p:P433

wds:Q46883619-B55DD992-9457-4FE8-9F4F-23FA79AC396B

p:P478

wds:Q46883619-14539777-A939-4EFA-8270-84877D4270B6

wdt:P433

3

wdt:P478

85

p:P356

wds:Q46883619-03637545-DEE0-4BD0-AFB2-91D4D9FEA6DB

wdtn:P356

n12:J.RADONC.2007.10.042

wdt:P356

10.1016/J.RADONC.2007.10.042